Deeper understandings of biological systems and advances in nanotechnology have provided new opportunities to make significant progress in mechanobiology, biosensing and dynamic control of engineered systems, with wide range of applications such as cancer research. In order to take advantage of these new opportunities, researchers must work at the intersection of biology and engineering, learning to operate effectively in both biological and engineering/physical science laboratories. Participation in the BioSensing BioActuation BioNanotechnology Summer Institute (B3SI) 2012 will give you the tools needed to operate effectively in an interdisciplinary environment.

About B3SI

The BioSensing BioActuation BioNanotechnology Summer Institute (B3SI) 2012 is a collaboration between the University of Illinois and National Taiwan University that will provide training in nanotechnology and biology research tools to address interdisciplinary research needs in biosensing bioactuation, cancer biology, and cell mechanics. B3SI integrates the National Science Foundation (NSF) and National Science Council of Taiwan (NSC) BioSensing BioActuation Summer Institute (BSBA) with the NSF and National Institutes of Health (NIH) sponsored BioNanotechnology Summer Institute (BNSI), to create a 2-week training experience on the University of Illinois at Urbana-Champaign campus.

About BSBA

The U.S. National Science Foundation (NSF) and the National Science Council (NSC) of Taiwan funded BSBA Summer Institute 2012 is part of a six year series (initial funding for three years), with alternate institutes planned in the U.S. and Taiwan. US Summer Institutes will be held at the University of Illinois at Urbana-Champaign (2010, 2012, 2014). The Taiwanese Summer Institutes will be held at the National Taiwan University (2011, 2013, 2015).

Sponsored by:

National Science Foundation, National Science Council of Taiwan, and the National Institutes of Health

Co-sponsors:

• Center for Nanoscale Science and Technology (CNST)
• Micro and Nanotechnology Laboratory (MNTL)
• NSF Integrative Graduate Education and Research Traineeship (IGERT) on Cellular and Molecular Mechanics and BioNanotechnology (CMMB)
• NIH/NCI Midwest Cancer Nanotechnology Training Center (M-CNTC)
• NSF STC on Emergent Behaviors of Integrated Cellular Systems (EBICS)
• Center for Agricultural, Biomedical, and Pharmaceutical Nanotechnology (CABPN), an NSF Industry/University
• Cooperative Research Center
• Center for Cellular Mechanics (CCM)
• University of Illinois colleges of Engineering, Liberal Arts and Sciences, and Veterinary Medicine

Dr. Clare is the co-Principal Investigator of the Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center. The Komen-Indiana Bank is the only tissue biorepository in the world established for the acquisition of normal breast tissue, i.e., from volunteer donors with out evidence of disease. She and her laboratory colleagues are members of an NIH R-01 funded Bioengineering Research Partnership, which is developing a nanobiochip for the functional assay of signal transduction pathways. Dr. Clare and her group are also investigating using monocytes/macropahges as a Trogan Horse to deliver nanoparticles to primary and metastatic lesions.

Source: Dr. Clare's Research Profile

National Science Foundation, National Science Council of Taiwan, and the National Institutes of Health.

Researchers should cite this work as follows:

• Susan E. Clare; Charlie Newman; NanoBio Node (2012), "[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo," https://nanohub.org/resources/14921.

1. B3SI 2012
2. Beckman Institute
3. Breast Cancer
4. Cancer Biology
5. Illinois
6. Indiana
7. Medical
8. medicine
9. NanoBio Node
10. Surgery